For a profitable business, equity is the most expensive money there is. Every share sold cheaply while the company is still gaining value hands a permanent claim on future profit to someone else. That single fact is why non-dilutive funding for Indian SMEs has moved from a fringe option to a serious rung on the capital ladder. The lenders have multiplied, the pricing has tightened, and the instruments have matured enough to be taken seriously.
The trap is treating them as one thing. Venture debt, non-convertible debentures, and structured credit all raise money without selling equity, and they suit very different businesses. Choose wrong, and the cost shows up in cash flow for years. Choose right, and you have funded growth while keeping the equity you spent years building.
Why Non-Dilutive Funding Is Having a Moment
The backdrop explains the timing. Bank credit growth to companies slowed to around 11 per cent in the last financial year, leaving a gap that private lenders moved quickly to fill. Venture debt deployment in India reached roughly 1.3 billion dollars in 2025, while larger-ticket growth credit for late-stage companies touched about 1.68 billion dollars. The wider private credit market was larger still, with more than 9 billion dollars invested across 79 sizeable deals in the first half of 2025 alone.
Capital is available for any company that can service it. The real work, and the whole case for non-dilutive funding, is matching the instrument to the shape of the business, which is where a firm like Lorvet spends much of its time.
Venture Debt: Runway Without a Down Round
Venture debt is a term loan for companies that have already raised institutional equity and can show real revenue. It typically runs 12 to 36 months, priced between 12 and 18 per cent and most often in the 13 to 15 per cent band, with an interest-only period of three to six months before repayment begins. Lenders size it at roughly 20 to 35 per cent of the last equity round.
The catch is the warrant. Lenders take a small equity option, usually well under 2 per cent on a fully diluted basis, which is why the honest label is “less dilutive” rather than fully non-dilutive.
The market is concentrated among a handful of specialists. Alteria Capital has deployed over Rs 3,000 crore and Trifecta Capital more than Rs 4,000 crore, alongside Stride Ventures and InnoVen. They operate as SEBI-registered Category II Alternative Investment Funds or RBI-registered Non-Banking Financial Companies, not as banks, which is what lets them move faster and underwrite on enterprise value rather than hard collateral. For a company bridging the gap between equity rounds, this is often the cleanest option on the table.
NCDs: The Workhorse Instrument
A non-convertible debenture is a straightforward debt security. The company borrows a fixed sum, pays a defined coupon, and repays at maturity, with a debenture trustee holding security for the lenders. It cannot convert into equity, which is precisely the appeal. NCDs are the workhorse of Indian private credit and make up the bulk of private debt raised each year.
Pricing depends on who is lending. A privately placed NCD to a credit fund can carry a coupon of 14 to 16 per cent or more, sometimes with a portion compounded, reflecting the risk the fund takes. A listed, rated NCD aimed at retail investors sits lower, with AA-rated issuers offering roughly 9 to 11 per cent.
One structural point catches many founders out: a limited liability partnership cannot issue NCDs, so a business planning to use them has to be a company first. For an SME with predictable cash flow that can service a fixed coupon, the NCD is well understood, widely accepted, and clean to administer.
Structured Credit: Shaping Repayment Around the Business
Structured credit is the most flexible of the three and the most bespoke. Rather than a fixed monthly repayment starting immediately, the instrument is built around the borrower’s cash flow. Repayment can be a bullet at maturity, easing pressure in the early years; coupons can step up as the business scales; and the structure can blend senior debt, mezzanine tranches, and convertible elements. These deals are delivered by SEBI-registered AIFs and built one at a time.
That flexibility suits a specific situation. A company funding a capacity expansion, where the new cash flows arrive a year or two after the spending, benefits from repayment timed to those flows rather than an installment that starts the month after disbursement. The cost is higher than a bank loan, and the documentation is heavier, with information rights, board observation and financial covenants all standard. In exchange, the schedule fits the business instead of fighting it. Deciding whether that trade is worth it, deal by deal, is exactly the sort of structuring Lorvet works through with founders.
The Cost, and the Catch
None of this is free money, and treating it as a soft alternative to equity is how founders get into trouble. Debt has to be serviced whether or not the quarter goes to plan. Covenants can restrict how the company operates, security usually means a charge over assets, and venture debt adds a warrant on top. If cash flow falters, a fixed coupon becomes a threat in a way that patient equity never is.
Equity still wins for a genuinely pre-profit company that cannot reliably service debt, or where a strategic investor brings something money alone cannot. The strength of the non-dilutive approach is precisely that it presumes a business already generating cash, which is exactly the SME this market was built for.
Matching Capital to Cash Flow
The choice comes down to the shape of the company’s cash flow and the certainty of its repayment capacity. Steady, predictable earnings point towards an NCD. A post-equity company extending its runway leans towards venture debt. Lumpy, back-ended returns from a capex cycle argue for a structured facility with repayment matched to those flows.
The figures move quickly here, as SEBI rules, coupons and lender appetite all shift, so any decision should rest on current terms rather than last year’s. Working through which of the three fits, and negotiating the terms that follow, is the kind of engagement Lorvet takes on before anything is signed. Chosen well, non-dilutive funding for Indian SMEs turns a profitable balance sheet into growth capital while leaving the founder’s ownership intact.
Frequently Asked Questions
1.What is the difference between non-dilutive funding and equity funding?
Non-dilutive funding raises money the company must repay through debt instruments such as venture debt, NCDs or structured credit without selling ownership. Equity funding sells shares, which brings in capital that never has to be repaid but permanently reduces the founder’s stake and often their control. Non-dilutive suits profitable companies that can service repayments; equity suits businesses that cannot yet.
2.Can an LLP raise venture debt or issue NCDs?
An LLP cannot issue non-convertible debentures, which are a company-only instrument, so a business set on the NCD route must convert to a company first. Venture debt is more flexible on structure, but lenders strongly prefer a company with institutional equity backing, so most LLPs will need to reorganise before either route is realistically open.
3.How much does non-dilutive funding actually cost?
It varies by instrument. Venture debt is typically priced between 12 and 18 per cent, most often 13 to 15 per cent, plus a small warrant. Privately placed NCDs to credit funds can run 14 to 16 per cent or higher, while listed AA-rated NCDs sit closer to 9 to 11 per cent. Structured credit is priced deal by deal and is usually higher than a bank loan, reflecting its flexibility.
4.Is venture debt truly non-dilutive?
Not entirely. Venture debt carries a warrant, a small equity option usually well under 2 per cent on a fully diluted basis, so the accurate description is “less dilutive” rather than fully non-dilutive. It still preserves far more ownership than an equity round, which is why growth-stage companies use it to extend runway between rounds.
5.Which non-dilutive instrument is right for my business?
It depends on the shape of your cash flow. Steady, predictable earnings that can service a fixed coupon suit an NCD. A post-equity company bridging to its next round suits venture debt. A capex cycle with back-ended returns suits a structured facility with repayment matched to those flows. Because terms shift constantly, the fit should be tested against current market pricing rather than last year’s benchmarks.
